202 related articles for article (PubMed ID: 31772538)
1. Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography.
Miyazaki T; Ashikaga T; Fukushima T; Hatano Y; Sasaoka T; Kurihara K; Ono Y; Shimizu S; Otomo K; Hirao K
J Interv Cardiol; 2019; 2019():6515129. PubMed ID: 31772538
[TBL] [Abstract][Full Text] [Related]
2. Excimer laser coronary angioplasty combined with drug-coated balloon in the treatment of in-stent restenosis.
He P; Chen H; Yang J; Gao L; Guo J; Chen Y; Wang Q
Lasers Surg Med; 2024 Jul; 56(5):474-484. PubMed ID: 38738401
[TBL] [Abstract][Full Text] [Related]
3. Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.
Nishino M; Lee Y; Nakamura D; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
J Invasive Cardiol; 2012 Oct; 24(10):478-83. PubMed ID: 23043029
[TBL] [Abstract][Full Text] [Related]
4. The effect of the debulking by excimer laser coronary angioplasty on long-term outcome compared with drug-coating balloon: insights from optical frequency domain imaging analysis.
Sato T; Tsuchida K; Yuasa S; Taya Y; Koshikawa T; Tanaka K; Fujita S; Ikeda Y; Takahashi M; Okabe M; Oda H; Aizawa Y
Lasers Med Sci; 2020 Mar; 35(2):403-412. PubMed ID: 31264007
[TBL] [Abstract][Full Text] [Related]
5. Treatment of in-stent restenosis with excimer laser coronary angioplasty: benefits over scoring balloon angioplasty alone.
Hirose S; Ashikaga T; Hatano Y; Yoshikawa S; Sasaoka T; Maejima Y; Isobe M
Lasers Med Sci; 2016 Nov; 31(8):1691-1696. PubMed ID: 27516177
[TBL] [Abstract][Full Text] [Related]
6. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
[TBL] [Abstract][Full Text] [Related]
7. Real-life experience of a stent-less revascularization strategy using a combination of excimer laser and drug-coated balloon for patients with acute coronary syndrome.
Harima A; Sairaku A; Inoue I; Nishioka K; Oka T; Nakama Y; Dai K; Ohi K; Hashimoto H; Kihara Y
J Interv Cardiol; 2018 Jun; 31(3):284-292. PubMed ID: 29464846
[TBL] [Abstract][Full Text] [Related]
8. Impact of in-stent tissue characteristics on excimer laser coronary angioplasty prior to drug-coated balloon treatment.
Ishihara T; Dohi T; Nakamura D; Kikuchi A; Okamoto N; Mori N; Iida O; Tsujimura T; Mizote I; Higuchi Y; Yamada T; Nishino M; Mano T; Sakata Y;
Int J Cardiol; 2021 Sep; 339():28-32. PubMed ID: 34265314
[TBL] [Abstract][Full Text] [Related]
9. The impact of tissue characterization for in-stent restenosis with optical coherence tomography during excimer laser coronary angioplasty.
Hashimoto S; Takahashi A; Mizuguchi Y; Yamada T; Taniguchi N; Hata T; Nakajima S
Cardiovasc Interv Ther; 2019 Apr; 34(2):171-177. PubMed ID: 30136194
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Clinical Outcomes after Treatment with Excimer Laser Coronary Atherectomy for In-Stent Restenosis of Drug-Eluting Stent.
Ichimoto E; Kadohira T; Nakayama T; De Gregorio J
Int Heart J; 2018 Jan; 59(1):14-20. PubMed ID: 29332914
[TBL] [Abstract][Full Text] [Related]
11. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions.
Li H; Ai H; Li L; Zheng N; Tang G; Yang G; Zhao Y; Sun F; Zhang H
BMC Cardiovasc Disord; 2021 Aug; 21(1):399. PubMed ID: 34407770
[TBL] [Abstract][Full Text] [Related]
13. Treatment of In-Stent Restenosis Using Excimer Laser Coronary Atherectomy and Bioresorbable Vascular Scaffold Guided by Optical Coherence Tomography.
Pereira GTR; Dallan LAP; Vergara-Martel A; Alaiti MA; Bezerra HG
Cardiovasc Revasc Med; 2021 Jan; 22():44-49. PubMed ID: 32448779
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcomes of excimer laser coronary atherectomy for the management of recurrent in-stent restenosis.
Farag M; van den Buijs D; Loh SX; Poels E; Ameloot K; Janssens L; Bennett J; Tahon J; Dens J; Egred M
J Invasive Cardiol; 2023 Jul; 35(7):E365-E374. PubMed ID: 37769620
[TBL] [Abstract][Full Text] [Related]
15. The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study.
Ambrosini V; Golino L; Niccoli G; Roberto M; Lisanti P; Ceravolo R; Bernardi G; Armigliato P; Gabrielli G; Chizzola G; De Paulis C; Crea F; Colombo A
Cardiovasc Revasc Med; 2017; 18(3):165-168. PubMed ID: 28081977
[TBL] [Abstract][Full Text] [Related]
16. The state of the excimer laser for coronary intervention in the drug-eluting stent era.
Badr S; Ben-Dor I; Dvir D; Barbash IM; Kitabata H; Minha S; Pendyala LK; Loh JP; Torguson R; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2013; 14(2):93-8. PubMed ID: 23332778
[TBL] [Abstract][Full Text] [Related]
17. Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study.
Kim HO; Jung HW; Lee JH; Kim JS; Hong SJ; Ahn CM; Kim BK; Kim W; Kim SJ; Kim W; Ko YG; Choi D; Hong MK; Jang Y
Coron Artery Dis; 2020 Dec; 31(8):694-702. PubMed ID: 32976245
[TBL] [Abstract][Full Text] [Related]
18. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
[TBL] [Abstract][Full Text] [Related]
19. Effect of drug-coated balloon on stent restenosis, neointimal proliferation, and coronary dissection: an optical coherence tomography analysis.
Fukushima T; Ashikaga T; Yoshikawa S; Hatano Y; Ueshima D; Yamamoto T; Yasuhiro M; Isobe M
Coron Artery Dis; 2018 Jan; 29(1):39-45. PubMed ID: 28902718
[TBL] [Abstract][Full Text] [Related]
20. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
